EVERSENS SL 

Company specializing in non-invasive clinical diagnosis through the detection of exhaled biomarkers

OWNER

EVERSENS SL (See Profile)

Sector

Medical Device

Stage

Development, market readiness, clinical trial

Country

Spain


evernoa, a point-of-care, portable, FeNO solution (biomarker of airways inflammation)

evernoa includes, four portable devices to measure exhaled biomarkers and a software e-platform that connects them.

Bait and hook revenue model with recurrent incomes

Market segments: Hospitals, Primary Care, Pharmacies, Health Insurance Companies, Asthma and Covid-19 patients

Two international patents, EU design registration and trademarks

This information is confidential, do not share or copy.

Under evaluation at least till: 20th May

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2020 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar